-
公开(公告)号:KR101912814B1
公开(公告)日:2018-10-29
申请号:KR1020180103629
申请日:2018-08-31
Abstract: 본발명은쌀겨추출물분말의제조방법에관한것으로, 쌀겨추출물의산패를효과적으로억제하고, 상기쌀겨추출물을분무건조했을때 생산수율및 분말의흐름성을현저히향상시킬수 있는쌀겨추출물분말의제조방법을제공하는것이다. 본발명에따른쌀겨추출물분말의제조방법은쌀겨추출물의산패를억제하여쌀겨의유효성분을효과적으로보호하고, 상기쌀겨추출물을분무건조할때 생산수율및 분말의흐름성(유동성)을향상시킬수 있어가공성이뛰어난효과를나타낸다.
-
公开(公告)号:KR101899546B1
公开(公告)日:2018-09-17
申请号:KR1020170058387
申请日:2017-05-11
Applicant: 한국식품연구원
IPC: A61K31/047 , A23L33/10
CPC classification number: A23L33/10 , A23V2002/00 , A23V2200/31 , A61K31/047
Abstract: 본발명의플로로글루시놀을유효성분으로하는수면장애예방또는치료용약학조성물, 또는수면장애개선용건강기능식품조성물은빠르고신뢰성있게수면을유도하거나유지시키면서, 반복적인잠깸증상을방지할수 있고, 생리적인수면구조를변경시키지않으며, 특히불완전한주간활동이나인식능력을야기할수 있는잔류진정작용이없고, 장기간투여에의해서도내성이발생하지않고, 종래 GABA수용체효능제의부작용이발생하지않는다. 또한본 발명의플로로글루시놀을유효성분으로하는 GABA수용체효능제의내성억제또는부작용경감용약학조성물, 또는 GABA수용체효능제의내성억제또는부작용개선용건강기능식품조성물은 GABA수용체효능제의부작용을경감시키거나 GABA수용체효능제의장기투여에따른내성을억제할수 있다. 또한본 발명의플로로글루시놀및 GABA수용체효능제를유효성분으로하는수면장애예방또는치료용약학조성물은, 수면의양은증가시키나수면의질을저하시켜다양한부작용의원인이될 수있는 GABA수용체효능제의함량을줄임으로써 GABA수용체효능제의부작용을경감시키거나 GABA수용체효능제의장기투여에따른내성을억제할수 있다.
-
公开(公告)号:KR1020180100102A
公开(公告)日:2018-09-07
申请号:KR1020180103629
申请日:2018-08-31
CPC classification number: A23L7/198 , A23L29/03 , A23P10/47 , A23V2002/00 , A23V2200/02
Abstract: 본발명은쌀겨추출물분말의제조방법에관한것으로, 쌀겨추출물의산패를효과적으로억제하고, 상기쌀겨추출물을분무건조했을때 생산수율및 분말의흐름성을현저히향상시킬수 있는쌀겨추출물분말의제조방법을제공하는것이다. 본발명에따른쌀겨추출물분말의제조방법은쌀겨추출물의산패를억제하여쌀겨의유효성분을효과적으로보호하고, 상기쌀겨추출물을분무건조할때 생산수율및 분말의흐름성(유동성)을향상시킬수 있어가공성이뛰어난효과를나타낸다.
-
公开(公告)号:KR1020170141845A
公开(公告)日:2017-12-27
申请号:KR1020160074553
申请日:2016-06-15
Applicant: 한국식품연구원
IPC: A61K36/734 , A23L1/30
Abstract: 본발명은산사() 추출물을유효성분으로서포함하는우울증치료또는예방약제학적조성물에관한것이다. 본발명의조성물은신경세포를보고하고우울증을치료또는개선시키는효과가있다. 이로인해, 종래항우울제의부작용을극복하고동시에우울증치료효과를가져올수 있다는이점이있다.
Abstract translation: 本发明涉及包含Acantha sp。()提取物作为活性成分的治疗性或预防性抑郁药物组合物。 本发明的组合物在报告神经细胞和治疗或改善抑郁症方面是有效的。 这具有克服过去抗抑郁药的不良副作用的优点,同时带来抑郁症的治疗效果。
-
公开(公告)号:KR1020130089969A
公开(公告)日:2013-08-13
申请号:KR1020120006006
申请日:2012-01-19
Applicant: 한국식품연구원
Abstract: PURPOSE: A one stop platform system establishes libraries required to develop a functional food by unit technology and provides those having a development demand for functional foods with relevant information in a comprehensive manner. CONSTITUTION: A database (140) contains a first library (210) having information about the functionality of several ingredients of a functional food and a second library (230) having information about the raw materials and manufacturing processes corresponding to each ingredient of the first library. An input/output module communicates with a user device. By using the information of the first library and the second library as well as the relations between the two libraries, a management module selectively provides the user device with the functionality information or the raw material/manufacturing process information of a certain functional food via the input/output module. [Reference numerals] (210) Functional material library; (230) Raw material normalization and manufacturing process library; (250) Functionality evaluation library; (AA) Raw material information; (B1) Function/reference component analysis method (1); (B2) Function/reference component analysis method (2); (B3) Function/reference component analysis method (3); (CC) Processing information; (D1) Extracting process (1); (D2) Extracting process (2); (D3) Powdering process (1); (D4) Powdering process (2); (EE) Material-specific functionality information; (F1) Raw material A; (F10,F15,J2,L5) Functionality B; (F11,F16,J3) Functionality C; (F12,F17) Functionality D; (F13,F18) Functionality E; (F19) Human body applying test document; (F2) Material A1; (F20) Animal test document; (F21) In vitro test document; (F3) Material A2; (F4) Material A3; (F5) Raw material B; (F6) Material B1; (F7) Material B2; (F8) Material B3; (F9,F14,J1,L1) Functionality A; (GG) Material-specific traditional purpose; (H1) Material A; (H2) Material B; (H3) Material C; (H4,H5,H6) Traditional purpose; (II) Functionality screening; (J4,J5,J6,L2,L6) In vitro test; (KK) Functionality evaluation; (L3,L7) In vivo test; (L4,L8) Human body test
Abstract translation: 目的:一站式平台系统建立了以单位技术开发功能性食品所需的图书馆,并为具有综合性的相关信息功能食品开发需求提供了依据。 构成:数据库(140)包含第一库(210),其具有关于功能食品的若干成分的功能的信息,以及第二库(230),其具有关于与第一库的每个成分对应的原材料和制造过程的信息 。 输入/输出模块与用户设备进行通信。 通过使用第一库和第二库的信息以及两个库之间的关系,管理模块通过输入有选择地向用户设备提供功能信息或特定功能食品的原材料/制造过程信息 /输出模块。 (附图标记)(210)功能材料库; (230)原料标准化与制造过程库; (250)功能评估库; (AA)原材料信息; (B1)功能/参考成分分析方法(1); (B2)功能/参考分量分析方法(2); (B3)功能/参考分量分析方法(3); (CC)处理信息; (D1)提取工序(1); (D2)提取过程(2); (D3)粉化工序(1); (D4)粉化工序(2); (EE)材料特定功能信息; (F1)原料A; (F10,F15,J2,L5)功能B; (F11,F16,J3)功能C; (F12,F17)功能D; (F13,F18)功能E; (F19)人体应用测试文件; (F2)材料A1; (F20)动物试验文件; (F21)体外试验文件; (F3)材料A2; (F4)材料A3; (F5)原料B; (F6)材料B1; (F7)材料B2; (F8)材料B3; (F9,F14,J1,L1)功能A; (GG)物质专用传统用途; (H1)材料A; (H2)材料B; (H3)材料C; (H4,H5,H6)传统用途; (二)功能筛选; (J4,J5,J6,L2,L6)体外试验; (KK)功能评估; (L3,L7)体内试验; (L4,L8)人体试验
-
公开(公告)号:KR1020210047414A
公开(公告)日:2021-04-30
申请号:KR1020190130749
申请日:2019-10-21
Applicant: 한국식품연구원
IPC: A61K36/9066 , A61K31/12 , A61P25/20 , A23L33/105 , A23K10/30
Abstract: 본발명은강황추출물을유효성분으로함유하는수면장애의예방, 개선또는치료용조성물에관한것이다. 본발명의강황추출물은종래수면유도제로사용되는의약인레돌민또는디아제팜과거의동일한수준또는향상된수준으로입면시간의감소, 수면지속시간의증가및 논렘수면의증가효과를제공한다. 또한, 본발명의강황추출물은종래히스타민수용체길항제로알려진피릴아민말리에이트염의수면효과가히스타민수용체효능제인 2-피리딜에틸아민디히드로클로라이드에의해완전히억제되는것과마찬가지기작으로수면효과가억제되어, 천연항히스타민제로서작용한다. 또한, 천연물인강황으로부터유래한것이어서장기간사용하여도인지장애(cognitive impairment), 내성또는의존성이형성되는부작용이없다. 따라서, 본발명의강황추출물을유효성분으로포함하는수면장애예방, 개선또는치료용조성물은경쟁력있는식품조성물및 의약조성물의제조에매우유용하다.
-
公开(公告)号:KR1020210033971A
公开(公告)日:2021-03-29
申请号:KR1020210036000
申请日:2021-03-19
Applicant: 한국식품연구원
IPC: A61K36/64 , A23L33/105 , A23K10/30
Abstract: 본발명은송이풀추출물을유효성분으로포함하는우울증예방또는치료용약제학적조성물; 여성갱년기증후군예방또는치료용약제학적조성물; 기능성사료첨가제조성물; 인지기능장애예방또는치료용조성물; 또는항스트레스조성물에관한것이다. 본발명의조성물은신경세포보호효과가있으며, 특히스트레스또는우울증증상으로인해감소하는 BDNF (brain derivated neurotrophic factor) 발현회복효과및 스트레스부여에따른인지기능저하의개선효과가있다.
-
-
-
-
-
-
-